2-Chloro-3-((trimethylsilyl)ethynyl)pyridin-4-amine, 97%, 1g

2-Hydroxy-2-(3-phenoxyphenyl)acetonitrile, 95.0%, 100mg

N,N'-[(Perfluoropropane-2,2-diyl)bis(6-hydroxy-3,1-phenylene)]bis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxamide)>98.0%(HPLC)(T)1g

5-Hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 95%, 250mg

N-(4-Isopropylphenyl)-2-chloropropanamide, 98%, 10g

4-(6-chloro-3-pyridazinyl)thiomorpholine, 95.0%, 5g

2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid, 95.0%, 5mg

2-Amino-4-fluoropyridine, 98.0%, 1g

TERT-BUTYL 5-OXO-2,6-DIAZASPIRO[3.4]OCTANE-2-CARBOXYLATE, 95.0%, 250mg

rEGCase I1vial

2-Methoxy-4-(methoxymethoxy)benzaldehyde, 97%, 250mg

3,4-Dichlorophenylacetone, 96.0%, 1g

Benzyl (tert-butoxycarbonyl)-L-phenylalaninate, 98%, 100g